Evidence map›Paper›PMID 17050583›Full record

ArticleThe British journal of ophthalmology2007

Comparison of an rRNA-based and DNA-based nucleic acid amplification test for the detection of Chlamydia trachomatis in trachoma.

Jon L Yang, Julius Schachter, Jeanne Moncada, Dereje Habte, Mulat Zerihun, Jenafir I House, Zhaoxia Zhou, Kevin C Hong, Kathryn Maxey, Bruce D Gaynor and 1 more

Open access · greenAbstract readComparative StudyEvaluation Study
In one paragraph

Article in The British journal of ophthalmology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.7field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 38 citations in OpenAlex.

  1. Trial
  2. Trial
  3. How reliable are tests for trachoma?--a latent class approach.Investigative ophthalmology & visual science · 2011
    Trial
  4. Article
  5. Comparison between DNA- and RNA-based nucleic acid amplification tests for detecting Mycoplasma pneumoniae in pediatric specimens.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Trachoma: an update on prevention, diagnosis, and treatment.Current opinion in ophthalmology · 2012
    Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. rRNA-based tests for chlamydial infection in trachoma.The British journal of ophthalmology · 2007
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Jon L YangF.I. Proctor Foundation, University of California San Francisco, San Francisco, CA 94143-0412, USA.
Julius Schachter
Jeanne Moncada
Dereje Habte
Mulat Zerihun
Jenafir I House
Zhaoxia Zhou
Kevin C Hong
Kathryn Maxey
Bruce D Gaynor
Thomas M Lietman
University of California, San Francisco · USSan Francisco Foundation · USThe Carter Center · ET

Funding

TANA IIU10EY016214 · NEI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI LIETMAN, THOMAS M · 2004 to 2013
$4.4M
Azithromycin in Control of Trachoma IIR01AI048789 · NIAID · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI SCHACHTER, JULIUS · 2001 to 2005
$3.5M
NEI NIH HHS U10 EY016214NIAID NIH HHS R01 AI048789NIAID NIH HHS R01 AI48789
6 · The paper itself

Abstract

BACKGROUND/

aimThe World Health Organisation (WHO) hopes to achieve global elimination of trachoma, still the leading cause of preventable blindness worldwide, in part through mass antibiotic treatment. DNA-based nucleic acid amplification tests (NAATs) are currently used to evaluate the success of treatment programmes by measuring the prevalence of C trachomatis infection. Some believe that newer ribosomal RNA (rRNA)-based tests may be much more sensitive since bacterial rRNA is present in amounts up to 10 000 times that of genomic DNA. Others believe that rRNA-based tests are instead less sensitive but more specific, due to the presence of dead or subviable organisms that the test may not detect. This study compares an rRNA-based test to a DNA-based test for the detection of ocular C trachomatis infection in children living in trachoma-endemic villages.

methodsAn rRNA-based amplification test and DNA-based polymerase chain reaction (PCR) were performed on swab specimens taken from the right upper tarsal conjunctiva of 56 children aged 0-10 years living in two villages in Amhara, Ethiopia.

resultsThe rRNA-based test detected ocular C trachomatis infection in 35 (63%) subjects compared with 22 (39%) detected by PCR (McNemar's test, p = 0.0002). The rRNA-based test gave positive results for all subjects that were positive by PCR, and also detected infection in 13 (23%) additional subjects.

conclusionThe rRNA-based test appears to have significantly greater sensitivity than PCR for the detection of ocular chlamydial infection in children in trachoma-endemic villages. Using the rRNA-based test, we may be able to detect infection that was previously missed with PCR. Past studies using DNA-based tests to assess prevalence of infectious trachoma following antibiotic treatment may have underestimated the true prevalence of infection.

Indexed as

ChildChild, PreschoolChlamydia trachomatisConjunctivaDNA, BacterialFemaleHumansInfantInfant, NewbornMalePolymerase Chain ReactionReproducibility of ResultsRNA, BacterialRNA, RibosomalTrachomaDNA, BacterialRNA, BacterialRNA, Ribosomal

Identifiers

PMID17050583
PMCPMC1857674
OpenAlexW1990648368

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.